Recent Updates
Recently added Catalysts
BDX Neutral Sentiment Score: 60/100

BD to Announce Fiscal 2023 Fourth Quarter and Full Year Financial Results BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will report its fiscal 2023...

Key Takeaway: Becton, Dickinson and Company (BDX) announced that it will report its fiscal 2023 fourth quarter and full year financial results on November 9, 2023. The company will issue a news release detailing the financial information and host an audio webcast at 8 a.m. ET that same day to discuss the results and provide updates on operations and strategy. BD emphasizes its commitment to transparency and investor relations through this announcement.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is set to provide its financial results, showcasing transparency.
  • The announcement reflects BD’s commitment to keeping investors informed.
  • The upcoming webcast indicates a proactive approach to investor relations.

Full Press Release Details

FRANKLIN LAKES, N.J. , Oct. 12, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will report its fiscal 2023 fourth quarter and full year financial results on Thursday, November 9, 2023 . A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation materials. The news release and presentation materials will include summary financial information for the company's fiscal 2023 fourth quarter and full year financial results, which ended on Saturday, September 30 , 2023.
BD management will host an audio webcast at 8 a.m. ET on November 9, 2023 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .
Contacts:
Media : Investors :
Troy Kirkpatrick Adam Reiffe
VP, Public Relations Sr. Director, Investor Relations
858.617.2361 201.847.6927
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When will BD report its fiscal 2023 financial results?

BD will report its financial results on November 9, 2023.

What time is the audio webcast scheduled for November 9, 2023?

The audio webcast will begin at 8 a.m. ET.

Where can I find the financial news release?

The news release will be available at www.bd.com/investors.

What date marks the end of BD's fiscal year 2023?

BD's fiscal year 2023 ended on September 30, 2023.

How many employees does BD have?

BD employs approximately 77,000 people worldwide.

Last updated: Oct 12, 2023